Biotech / Pharma
Catalyst Pharmaceuticals
Biotech / Pharma
Angelini Pharma closed its $4.1B acquisition of Catalyst Pharmaceuticals, funded partly by €1B of preferred equity from Blackstone and a €1B investment from Italy's CDP Equity for a 23.5% stake in the Italian drugmaker.
Founded
Region
Investors
People